Neoadjuvant Therapy Prior to Prostatectomy: Is the Glass Half Full?

Eur Urol. 2023 Jun;83(6):519-520. doi: 10.1016/j.eururo.2023.01.021. Epub 2023 Jan 27.

Authors

Bruce Montgomery¹, Elahe A Mostaghel²

Affiliations

¹ University of Washington School of Medicine, Seattle, WA, USA; VA Puget Sound Health Care System, Seattle, WA, USA. Electronic address: rbmontgo@uw.edu.
² University of Washington School of Medicine, Seattle, WA, USA; VA Puget Sound Health Care System, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA.

PMID: 36710203
DOI: 10.1016/j.eururo.2023.01.021

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antineoplastic Agents, Hormonal
Humans
Male
Neoadjuvant Therapy*
Prostatectomy*

Substances

Antineoplastic Agents, Hormonal

Associated data

ClinicalTrials.gov/NCT05498272
ClinicalTrials.gov/NCT04030559